Central venous stenosis: Use of transluminal angioplasty and endovascular Wallstents: Central venous stenoses are a frequent complication in hemodialysis patients. These lesions lead to fistula thromboses, arm swelling, and limit future vascular access. Stenoses are characterized by excellent initial response to transluminal angioplasty but rapid recurrence. Response to angioplasty allows classification of stenoses as elastic or nonelastic. The success of angioplasty alone in 30 patients with central venous stenoses was compared to angioplasty and Wallstent placement in 11 patients with recurrent stenoses. In those who had angioplasty alone, 7% failed angioplasty, 70% had ≥ 50% improvement in the luminal diameter while 23% showed no improve...
Stenting of central venous stenoses in hemodialysis patients: Long-term results. From November 1992 ...
Central venous stenosis is an important hindrance to long-term maintenance of arteriovenous access i...
Maintenance of hemodialysis access for end-stage renal disease continues to be a major challenge for...
Central venous stenosis: Use of transluminal angioplasty and endovascular Wallstents: Central venous...
There is no doubt that the optimal vascular access is arteriovenous fistula (AVF). However, the prop...
AbstractCentral vein stenosis is common because of the placement of venous access and cardiac intrav...
Percutaneous transluminal angioplasty (PTA) has assumed an important role in the chronic management ...
ABSTRACT A major challenge in the management of hemodialysis patients is central venous stenosis and...
AbstractObjectivesThe increased use of central venous access primarily for hemodialysis has led to a...
Central venous stenosis is a significant and frequently encountered problem in managing hemodial...
ObjectiveCentral vein stenosis or occlusion remains an unfortunate complication associated with the ...
ObjectivesCovered stents have been proposed as an endovascular option for recalcitrant cases of hemo...
Central vein stenosis (CVS) is common in hemodialysis patients caused by the implantation of cardiac...
The purpose of this study was to evaluate the long-term outcomes of endovascular treatment of centra...
Background: Central venous disease is a serious complication in patients undergoing hemodialysis, of...
Stenting of central venous stenoses in hemodialysis patients: Long-term results. From November 1992 ...
Central venous stenosis is an important hindrance to long-term maintenance of arteriovenous access i...
Maintenance of hemodialysis access for end-stage renal disease continues to be a major challenge for...
Central venous stenosis: Use of transluminal angioplasty and endovascular Wallstents: Central venous...
There is no doubt that the optimal vascular access is arteriovenous fistula (AVF). However, the prop...
AbstractCentral vein stenosis is common because of the placement of venous access and cardiac intrav...
Percutaneous transluminal angioplasty (PTA) has assumed an important role in the chronic management ...
ABSTRACT A major challenge in the management of hemodialysis patients is central venous stenosis and...
AbstractObjectivesThe increased use of central venous access primarily for hemodialysis has led to a...
Central venous stenosis is a significant and frequently encountered problem in managing hemodial...
ObjectiveCentral vein stenosis or occlusion remains an unfortunate complication associated with the ...
ObjectivesCovered stents have been proposed as an endovascular option for recalcitrant cases of hemo...
Central vein stenosis (CVS) is common in hemodialysis patients caused by the implantation of cardiac...
The purpose of this study was to evaluate the long-term outcomes of endovascular treatment of centra...
Background: Central venous disease is a serious complication in patients undergoing hemodialysis, of...
Stenting of central venous stenoses in hemodialysis patients: Long-term results. From November 1992 ...
Central venous stenosis is an important hindrance to long-term maintenance of arteriovenous access i...
Maintenance of hemodialysis access for end-stage renal disease continues to be a major challenge for...